Table 6 Subgroup analyses on the impacts of DDDc
Categories | Drugs under the same generic name | Alternative drugs | ||||||
|---|---|---|---|---|---|---|---|---|
Bid-winning | Generic | Branded | Total | Perfect | Fundamental | Limited | Total | |
ATC-C | ||||||||
Level change | -1.89*** | -1.02*** | -1.23*** | -1.18*** | -0.05** | -0.16*** | -0.01 | -0.11*** |
Trend change | -0.07* | 0.031* | -0.00 | -0.02 | 0.01** | -0.00 | -0.01 | -0.00 |
ATC-N | ||||||||
Level change | -11.53*** | -4.83*** | -3.35*** | -3.83*** | 0.12 | 0.026 | -0.07 | 0.30* |
Trend change | -0.36** | -0.22 | -0.07** | -0.28 | -0.22** | -0.00 | 0.12 | 0.01 |
ATC-J | ||||||||
Level change | -14.14*** | -3.97*** | -3.75*** | -4.23*** | -0.10 | -0.22* | -1.49 | -0.68 |
Trend change | -0.04 | -0.06 | -0.00 | -0.16* | -0.01 | -0.01 | -0.11 | -0.05 |
ATC-L | ||||||||
Level change | -4.02 | -46.79*** | -5.36 | -10.51 | - | -47.14*** | 3.42* | -13.29*** |
Trend change | 6.06* | 0.74 | 11.16*** | 6.23*** | - | 0.22 | 0.39 | 0.33 |
Others | ||||||||
Level change | -14.96*** | -3.13*** | -3.67*** | -5.27*** | - | - | 6.94 | 6.94 |
Trend change | 0.12* | 0.11*** | -0.19 | -0.15 | - | - | 0.84 | 0.84 |